Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.29
-0.07 (-0.95%)
At close: May 8, 2026, 4:00 PM EDT
7.37
+0.08 (1.10%)
After-hours: May 8, 2026, 5:09 PM EDT
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $53.86 million as of May 8, 2026. Its market cap has increased by 55.19% in one year.
Market Cap
53.86M
Enterprise Value
-15.70M
1-Year Change
55.19%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $53.86M, a decrease of -83.44%. That is a compound annual growth rate of -20.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 53.86M | 16.92% |
| Dec 31, 2025 | 46.06M | -6.05% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 60.61M |
| Lixte Biotechnology Holdings | 59.95M |
| ImageneBio | 59.17M |
| Instil Bio | 55.34M |
| Dogwood Therapeutics | 55.11M |
| MiNK Therapeutics | 54.82M |
| Estrella Immunopharma | 53.76M |
| Metagenomi Therapeutics | 53.08M |